Literature DB >> 34559269

Efficacy of triamcinolone acetonide-impregnated Gelfoam nasal pack in management of chronic sinusitis with nasal polyps following endoscopic sinus surgery: a perfectly matched, placebo-controlled trial study.

Reza Samarei1,2, Javad Rasouli3, Fatemeh Mehdikhani4.   

Abstract

PURPOSE: This perfectly matched, double-blinded, placebo-controlled trial study was performed to investigate the efficacy of triamcinolone acetonide (TAA)-impregnated Gelfoam nasal pack in management of different endotypes of chronic rhinosinusitis with nasal polyps (CRSwNP) following endoscopic sinus surgery (ESS).
METHODS: One hundred and four patients with bilateral CRSwNP undergoing ESS were selected and randomized to receive TAA-soaked nasal packing in one nostril and saline-impregnated dressing contra-laterally. Validated Perioperative Sinus Endoscopy (POSE) scoring system was used to assess the participants' condition at postoperative months 1, 3, 6, 12, and 18.
RESULTS: The treatment side of eosinophilic CRSwNP (EosCRSwNP) group had significantly better endoscopic scores than the contralateral control side in all follow-up visits (P < 0.05 for all comparisons) except for the first postoperative month. No significant difference was detected between the TAA- and saline-treated nostrils in the non-eosinophilic CRSwNP (nonEosCRSwNP) subgroup during the follow-up period. Intergroup comparisons revealed a borderline better POSE score for the treatment side of the EosCRSwNP group compared with the treatment nostril of the nonEosCRSwNP group at months 12 (P = 0.041) and 18 (P = 0.044). At the end of the study period, the treatment side of the EosCRSwNP group demonstrated better clinical response than the saline-treated side in terms of the total POSE scores (P = 0.019), middle turbinate synechia (P = 0.008), middle meatal narrowing (P = 0.010), ethmoid polypoid changes (P = 0.039), ethmoid polyposis (P = 0.027), ethmoid cavity secretions (P = 0.042), and sphenoid severity (P = 0.018).
CONCLUSION: TAA-soaked Gelfoam dressing following bilateral ESS was found to be an effective method for treating CRSwNP particularly for the eosinophilic endotype of the disease.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chronic rhinosinusitis with nasal polyps; Endoscopic sinus surgery; Eosinophils; Nasal packing; Triamcinolone

Mesh:

Substances:

Year:  2021        PMID: 34559269     DOI: 10.1007/s00405-021-07071-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  45 in total

1.  Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life.

Authors:  J Condemi; R Schulz; J Lim
Journal:  Ann Allergy Asthma Immunol       Date:  2000-05       Impact factor: 6.347

Review 2.  Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.

Authors:  Claus Bachert; Luo Zhang; Phillippe Gevaert
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

3.  Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.

Authors:  Adam S DeConde; Jess C Mace; Joshua M Levy; Luke Rudmik; Jeremiah A Alt; Timothy L Smith
Journal:  Laryngoscope       Date:  2016-11-12       Impact factor: 3.325

4.  Can a panel of clinical, laboratory, and pathological variables pinpoint patients with sinonasal polyposis at higher risk of recurrence after surgery?

Authors:  Giuseppe Brescia; Gino Marioni; Sebastiano Franchella; Giulia Ramacciotti; Carmelita Velardita; Luciano Giacomelli; Filippo Marino; Alessandro Martini
Journal:  Am J Otolaryngol       Date:  2015-01-30       Impact factor: 1.808

5.  Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study.

Authors:  David W J Côté; Erin D Wright
Journal:  Laryngoscope       Date:  2010-06       Impact factor: 3.325

Review 6.  Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.

Authors:  Ratika Gupta; Luz S Fonacier
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

7.  Chronic panrhinosinusitis without nasal polyps: long-term outcome after functional endoscopic sinus surgery.

Authors:  Roland Giger; Pavel Dulguerov; Didier Quinodoz; Daniel Leuba; Basile Nicolas Landis; Jean-Silvain Lacroix; Jean Paul Friedrich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-10       Impact factor: 3.497

8.  Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response.

Authors:  Jose Gurrola; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2017-10-26       Impact factor: 10.793

9.  Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese.

Authors:  Ping-Ping Cao; Hua-Bin Li; Bao-Feng Wang; Shui-Bin Wang; Xue-Jun You; Yong-Hua Cui; De-Yun Wang; Martin Desrosiers; Zheng Liu
Journal:  J Allergy Clin Immunol       Date:  2009-07-09       Impact factor: 10.793

10.  Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis.

Authors:  Lien Calus; Nicholas Van Bruaene; Cedric Bosteels; Sarah Dejonckheere; Thibaut Van Zele; Gabrielle Holtappels; Claus Bachert; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2019-06-14       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.